JP Stock MarketDetailed Quotes

4503 Astellas Pharma

Watchlist
  • 1381.5
  • +21.0+1.54%
20min DelayMarket Closed Apr 25 15:30 JST
2.50TMarket Cap48.92P/E (Static)

Astellas Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Operating cash flow (Indirect Method)
Cash from operating activities
32.96%279.99B
-31.30%37.72B
60.72%78.98B
159.59%49.42B
-46.99%210.59B
87.51B
-42.38%54.9B
-47.46%49.14B
-76.65%19.04B
32.62%397.25B
Net profit before non-cash adjustment
25.10%31.24B
-783.68%-118.36B
307.13%38.55B
7.78%50.5B
-81.14%24.97B
---48.66B
-71.03%17.31B
-89.34%9.47B
47.89%46.85B
-15.63%132.36B
Total adjustment of non-cash items
52.54%415.12B
230.12%210.49B
15.18%71.99B
249.45%47.99B
-5.87%272.14B
--132.14B
18.22%63.76B
706.05%62.5B
-82.84%13.73B
111.49%289.09B
-Depreciation and amortization
26.16%199.13B
8.90%51.16B
28.35%50.02B
116.26%50.27B
49.27%157.84B
--48.64B
104.30%46.98B
70.53%38.97B
-36.96%23.24B
32.70%105.74B
-Reversal of impairment losses recognized in profit and loss
137.63%187.56B
31,300.00%180.55B
-98.57%38M
-95.06%520M
-6.59%78.93B
--65.16B
-60.86%575M
263.71%2.67B
-52.19%10.54B
12.89%84.5B
-Other non-cash items
-19.62%28.43B
-230.98%-21.22B
5.13%21.94B
86.06%-2.8B
-64.23%35.37B
--18.34B
-45.01%16.2B
231.80%20.87B
-194.84%-20.05B
654.16%98.86B
Changes in working capital
-92.29%-166.37B
-107.92%-54.42B
-38.26%-31.56B
-18.11%-49.07B
-257.38%-86.52B
--4.03B
-42.17%-26.17B
-655.33%-22.83B
-37.57%-41.55B
-506.46%-24.21B
-Change in receivables
-87.20%-104.74B
-101.61%-51.64B
-18.41%-17.37B
-419.87%-26.79B
-1,053.80%-55.95B
---24.04B
-3.54%-25.61B
-629.79%-14.67B
150.00%8.37B
39.40%-4.85B
-Change in inventory
16.34%-50.23B
-28.30%-20.52B
-43.04%-16.97B
104.71%790M
-747.25%-60.04B
---15.42B
-730.77%-15.99B
-196.65%-11.87B
-507.39%-16.76B
-129.45%-7.09B
-Change in payables
-138.72%-11.41B
14.94%17.74B
-24.93%2.79B
30.42%-23.08B
340.07%29.47B
--43.49B
306.75%15.43B
307.15%3.71B
-88.79%-33.17B
-21.51%-12.27B
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
Tax refund paid
-124.28%-85.48B
-184.29%-21.69B
-74.53%-14.17B
-438.40%-36.82B
45.15%-38.11B
-15.53B
66.78%-7.63B
-223.77%-8.12B
79.08%-6.84B
-65.06%-69.48B
Other operating cash inflow (outflow)
1M
0
0
0
0
0
0
0
0
0
Operating cash flow
12.78%194.51B
-66.10%16.03B
57.98%64.81B
3.30%12.6B
-47.38%172.48B
--71.98B
-34.63%47.27B
-54.93%41.02B
-75.02%12.2B
27.32%327.77B
Investing cash flow
Net PPE purchase and sale
2.77%-37B
130.69%2.29B
-56.15%-15.6B
-39.11%-14B
-4.43%-38.06B
---10.53B
34.43%-7.47B
-79.69%-9.99B
-22.19%-10.06B
-18.55%-36.44B
Net intangibles purchase and sale
42.68%-19.17B
14.80%-6.37B
90.99%-1.04B
-93.45%-9.63B
35.56%-33.44B
---9.4B
19.58%-7.48B
26.99%-11.59B
49.47%-4.98B
-142.15%-51.89B
Net business purchase and sale
--0
--0
----
----
---784.97B
---190M
---20.61B
----
----
--0
Net investment product transactions
--12.92B
----
----
----
--0
--0
----
----
----
126.40%12.62B
Interest received (cash flow from investment activities)
-19.76%7.1B
-27.34%1.21B
-22.41%2.48B
15.68%1.64B
94.16%8.85B
--2.58B
56.69%1.66B
334.69%3.2B
393.38%1.42B
536.59%4.56B
Net changes in other investments
-3,033.31%-53.27B
-1,115.80%-27.85B
-129.96%-2.22B
-1,410.04%-17.36B
113.60%1.82B
---4.62B
69.66%-2.29B
206.84%7.4B
198.73%1.33B
15.85%-13.35B
Investing cash flow
89.43%-89.42B
15.11%-30.72B
97.89%-16.38B
-219.91%-39.35B
-900.95%-845.8B
---22.16B
-33.44%-36.19B
-4,895.84%-775.15B
35.75%-12.3B
-35.39%-84.5B
Financing cash flow
Net issuance payments of debt
-111.48%-88.52B
-29.45%-22.3B
-110.00%-51.11B
-72.16%65.14B
5,241.55%771.23B
--43.12B
-134.46%-17.23B
1,804.48%511.35B
1,460.00%234B
75.00%-15B
Net common stock issuance
35.17%-6.96B
50.00%-1M
0.00%-1M
35.17%-6.96B
82.27%-10.74B
---1M
0.00%-2M
---1M
-1.69%-10.73B
-19.40%-60.56B
Increase or decrease of lease financing
1.26%-13.08B
1.72%-3.2B
17.45%-2.82B
12.30%-2.88B
19.70%-13.25B
---3.29B
20.17%-3.26B
17.97%-3.42B
29.98%-3.28B
7.41%-16.5B
Cash dividends paid
-10.58%-128.99B
-5.55%-66.23B
--0
-16.43%-62.76B
-16.24%-116.65B
--0
-14.76%-62.75B
--0
-18.01%-53.9B
-17.74%-100.36B
Net other fund-raising expenses
-43.98%-23.81B
-231.52%-12.56B
85.54%-407M
-328.43%-4.46B
-414.11%-16.54B
---8.9B
-307.75%-3.79B
-322.52%-2.81B
-52.64%-1.04B
-27.15%-3.22B
Financing cash flow
-142.56%-261.37B
-19.85%-104.3B
-110.76%-54.34B
-107.22%-11.92B
413.90%614.06B
--30.93B
-798.18%-87.03B
1,550.27%505.12B
454.15%165.04B
9.56%-195.62B
Net cash flow
Beginning cash position
-10.92%335.69B
-12.28%292.99B
-46.05%302.93B
-10.92%335.69B
19.26%376.84B
--253.98B
-7.50%333.99B
79.38%561.49B
19.26%376.84B
-3.11%315.99B
Current changes in cash
-163.68%-156.27B
-56.69%-118.99B
97.42%-5.91B
-123.44%-38.67B
-224.40%-59.27B
--80.75B
-313.88%-75.94B
-662.97%-229.02B
1,075.16%164.94B
324.03%47.64B
Effect of exchange rate changes
-50.53%8.96B
244.00%5.87B
-364.43%-4.02B
-70.02%5.91B
37.12%18.11B
--957M
72.41%-4.07B
-79.39%1.52B
41.37%19.71B
18.74%13.21B
Cash adjustments other than cash changes
-200.00%-1M
----
----
--1M
--1M
--2M
----
----
----
----
End cash Position
-43.88%188.37B
-29.18%179.87B
-12.28%292.99B
-46.05%302.93B
-10.92%335.69B
--335.69B
-33.48%253.98B
-7.50%333.99B
79.38%561.49B
19.26%376.84B
Free cash flow
52.46%137.18B
-63.27%11.76B
377.65%48.17B
-186.63%-11.94B
-62.39%89.98B
--52.06B
-37.96%32B
-85.51%10.08B
-113.62%-4.17B
32.17%239.23B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Operating cash flow (Indirect Method)
Cash from operating activities 32.96%279.99B-31.30%37.72B60.72%78.98B159.59%49.42B-46.99%210.59B87.51B-42.38%54.9B-47.46%49.14B-76.65%19.04B32.62%397.25B
Net profit before non-cash adjustment 25.10%31.24B-783.68%-118.36B307.13%38.55B7.78%50.5B-81.14%24.97B---48.66B-71.03%17.31B-89.34%9.47B47.89%46.85B-15.63%132.36B
Total adjustment of non-cash items 52.54%415.12B230.12%210.49B15.18%71.99B249.45%47.99B-5.87%272.14B--132.14B18.22%63.76B706.05%62.5B-82.84%13.73B111.49%289.09B
-Depreciation and amortization 26.16%199.13B8.90%51.16B28.35%50.02B116.26%50.27B49.27%157.84B--48.64B104.30%46.98B70.53%38.97B-36.96%23.24B32.70%105.74B
-Reversal of impairment losses recognized in profit and loss 137.63%187.56B31,300.00%180.55B-98.57%38M-95.06%520M-6.59%78.93B--65.16B-60.86%575M263.71%2.67B-52.19%10.54B12.89%84.5B
-Other non-cash items -19.62%28.43B-230.98%-21.22B5.13%21.94B86.06%-2.8B-64.23%35.37B--18.34B-45.01%16.2B231.80%20.87B-194.84%-20.05B654.16%98.86B
Changes in working capital -92.29%-166.37B-107.92%-54.42B-38.26%-31.56B-18.11%-49.07B-257.38%-86.52B--4.03B-42.17%-26.17B-655.33%-22.83B-37.57%-41.55B-506.46%-24.21B
-Change in receivables -87.20%-104.74B-101.61%-51.64B-18.41%-17.37B-419.87%-26.79B-1,053.80%-55.95B---24.04B-3.54%-25.61B-629.79%-14.67B150.00%8.37B39.40%-4.85B
-Change in inventory 16.34%-50.23B-28.30%-20.52B-43.04%-16.97B104.71%790M-747.25%-60.04B---15.42B-730.77%-15.99B-196.65%-11.87B-507.39%-16.76B-129.45%-7.09B
-Change in payables -138.72%-11.41B14.94%17.74B-24.93%2.79B30.42%-23.08B340.07%29.47B--43.49B306.75%15.43B307.15%3.71B-88.79%-33.17B-21.51%-12.27B
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
Tax refund paid -124.28%-85.48B-184.29%-21.69B-74.53%-14.17B-438.40%-36.82B45.15%-38.11B-15.53B66.78%-7.63B-223.77%-8.12B79.08%-6.84B-65.06%-69.48B
Other operating cash inflow (outflow) 1M000000000
Operating cash flow 12.78%194.51B-66.10%16.03B57.98%64.81B3.30%12.6B-47.38%172.48B--71.98B-34.63%47.27B-54.93%41.02B-75.02%12.2B27.32%327.77B
Investing cash flow
Net PPE purchase and sale 2.77%-37B130.69%2.29B-56.15%-15.6B-39.11%-14B-4.43%-38.06B---10.53B34.43%-7.47B-79.69%-9.99B-22.19%-10.06B-18.55%-36.44B
Net intangibles purchase and sale 42.68%-19.17B14.80%-6.37B90.99%-1.04B-93.45%-9.63B35.56%-33.44B---9.4B19.58%-7.48B26.99%-11.59B49.47%-4.98B-142.15%-51.89B
Net business purchase and sale --0--0-----------784.97B---190M---20.61B----------0
Net investment product transactions --12.92B--------------0--0------------126.40%12.62B
Interest received (cash flow from investment activities) -19.76%7.1B-27.34%1.21B-22.41%2.48B15.68%1.64B94.16%8.85B--2.58B56.69%1.66B334.69%3.2B393.38%1.42B536.59%4.56B
Net changes in other investments -3,033.31%-53.27B-1,115.80%-27.85B-129.96%-2.22B-1,410.04%-17.36B113.60%1.82B---4.62B69.66%-2.29B206.84%7.4B198.73%1.33B15.85%-13.35B
Investing cash flow 89.43%-89.42B15.11%-30.72B97.89%-16.38B-219.91%-39.35B-900.95%-845.8B---22.16B-33.44%-36.19B-4,895.84%-775.15B35.75%-12.3B-35.39%-84.5B
Financing cash flow
Net issuance payments of debt -111.48%-88.52B-29.45%-22.3B-110.00%-51.11B-72.16%65.14B5,241.55%771.23B--43.12B-134.46%-17.23B1,804.48%511.35B1,460.00%234B75.00%-15B
Net common stock issuance 35.17%-6.96B50.00%-1M0.00%-1M35.17%-6.96B82.27%-10.74B---1M0.00%-2M---1M-1.69%-10.73B-19.40%-60.56B
Increase or decrease of lease financing 1.26%-13.08B1.72%-3.2B17.45%-2.82B12.30%-2.88B19.70%-13.25B---3.29B20.17%-3.26B17.97%-3.42B29.98%-3.28B7.41%-16.5B
Cash dividends paid -10.58%-128.99B-5.55%-66.23B--0-16.43%-62.76B-16.24%-116.65B--0-14.76%-62.75B--0-18.01%-53.9B-17.74%-100.36B
Net other fund-raising expenses -43.98%-23.81B-231.52%-12.56B85.54%-407M-328.43%-4.46B-414.11%-16.54B---8.9B-307.75%-3.79B-322.52%-2.81B-52.64%-1.04B-27.15%-3.22B
Financing cash flow -142.56%-261.37B-19.85%-104.3B-110.76%-54.34B-107.22%-11.92B413.90%614.06B--30.93B-798.18%-87.03B1,550.27%505.12B454.15%165.04B9.56%-195.62B
Net cash flow
Beginning cash position -10.92%335.69B-12.28%292.99B-46.05%302.93B-10.92%335.69B19.26%376.84B--253.98B-7.50%333.99B79.38%561.49B19.26%376.84B-3.11%315.99B
Current changes in cash -163.68%-156.27B-56.69%-118.99B97.42%-5.91B-123.44%-38.67B-224.40%-59.27B--80.75B-313.88%-75.94B-662.97%-229.02B1,075.16%164.94B324.03%47.64B
Effect of exchange rate changes -50.53%8.96B244.00%5.87B-364.43%-4.02B-70.02%5.91B37.12%18.11B--957M72.41%-4.07B-79.39%1.52B41.37%19.71B18.74%13.21B
Cash adjustments other than cash changes -200.00%-1M----------1M--1M--2M----------------
End cash Position -43.88%188.37B-29.18%179.87B-12.28%292.99B-46.05%302.93B-10.92%335.69B--335.69B-33.48%253.98B-7.50%333.99B79.38%561.49B19.26%376.84B
Free cash flow 52.46%137.18B-63.27%11.76B377.65%48.17B-186.63%-11.94B-62.39%89.98B--52.06B-37.96%32B-85.51%10.08B-113.62%-4.17B32.17%239.23B
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Market Hot Picks Market Hot Picks
No. Symbol Price
Alt
260A
417
Shin-Etsu Chemical
4063
4046.0
Metaplanet
3350
335
4
Astellas Pharma
4503
1381.5
5
Mitsubishi
8058
2678.0
Log In for the Full List
Unlock Now